MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology
July 24, 2024 08:15 ET
|
Mangoceuticals, Inc.
Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a leader in men’s health and wellness products including erectile dysfunction (ED),...